IMCD stock reports 4 percent EBITA growth in H1 2026

Published on 09/24/2026 at 23:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IMCD stock reported EUR 2.64 billion in first half 2026 revenue on July 29. EBITA reached EUR 285 million, while a new US commercial role adds a strategic angle.

Fotorealistisches Hafenlager mit Fässern und Containern für Spezialchemie-Distribution bei Sonnenuntergang — Chemiedistributions-Terminal am Hafen zeigt Betrieb von IMCD N.V., ISIN NL0010801007, in Rotterdam realistisch fotografiert, Illustration mit AI erstellt.

IMCD stock (ISIN NL0010801007) stood at EUR 93.84 on Euronext Amsterdam on September 24, 2026, while the specialty chemicals distributor reported first half 2026 EBITA of EUR 285 million. That result was 4 percent above the prior-year period, according to MarketScreener.

EBITA growth reaches 4 percent

IMCD's first half 2026 results covered the six months ended June 30, 2026. Revenue reached EUR 2.64 billion, while EBITA came to EUR 285 million, giving investors two operating measures for comparing the latest reporting period with the prior year.

The 4 percent EBITA increase is the clearest quantified signal in the half-year update. It shows that earnings growth continued even as the group expanded its distribution and formulation platform across specialty chemicals and ingredients.

US expansion adds a new angle

IMCD also created a new commercial leadership role for the United States. Indian Chemical News reported that Walter Ripple joined as Executive Vice President, Commercial, US, with responsibility for strengthening supplier and customer relationships and supporting organic growth.

The appointment links the current management agenda to the numbers from the first half. A larger US commercial push could influence future organic growth, but the latest reported benchmark remains the EUR 285 million EBITA result for the six months through June 30, 2026.

Stock remains below yearly high

On September 24, 2026, IMCD traded at EUR 93.84 on Euronext Amsterdam, up EUR 0.08 or 0.09 percent on the session. Its 52-week range was EUR 68.14 to EUR 105.05, placing the stock EUR 11.21 below the yearly high.

Market capitalization stood at EUR 5,540,779,234 on the same date, with volume at 103,472 shares. The combination of a 4 percent EBITA increase and a stock price still below its 52-week high gives investors a concrete framework for assessing the next reported update.